What is SINTX Technologies Inc (SINT) stock price today?

SINTX Technologies Inc (SINT) currently trades at $2.11 per share. The stock has a market capitalization of $8.86M and a P/E ratio of —x.

Is SINT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, SINTX Technologies Inc has a Smart Value Score of 15/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -44.77.

What is SINTX Technologies Inc's revenue and earnings?

SINTX Technologies Inc has trailing twelve-month (TTM) revenue of $1.02M with profit margins of 0.00%. Earnings per share (EPS) is $-6.16.

Is SINTX Technologies Inc financially healthy?

SINTX Technologies Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -44.77 places it in the distress.

SINT

SINTX Technologies Inc

NASDAQ: SINT · HEALTHCARE · MEDICAL DEVICES

$2.11

+6.03% today

Updated 2026-04-30

Market cap

$8.86M

P/E ratio

—

P/S ratio

8.71x

EPS (TTM)

$-6.16

Dividend yield

—

52W range

$2 – $7

Volume

0.0M

Market cap

$8.86M

P/E ratio

—

P/S ratio

8.71x

EPS (TTM)

$-6.16

Dividend yield

—

52W range

$2 – $7

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.7

Growth

4.5

Quality

2.5

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-44.8

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$10.17

+381.99%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -44.77 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-2.38M

- Revenue declining -46.50% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$601000.00	$2.63M	$1.25M	$1.02M	$1.02M
Net income	$-12.04M	$-8.26M	$-11.02M	$-17.08M	$-2.21M
EPS	—	—	—	—	$-6.16
Free cash flow	$-11.67M	$-14.64M	$-9.33M	$-8.76M	$-2.38M
Profit margin	-2,003.16%	-314.39%	-884.75%	-1,678.09%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SINT	$8.86M	15	4.7	2.5	5.0	4.5	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

SINTX Technologies Inc trades at $2.11. Our Smart Value Score of 15/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -44.77, it sits in the distress. TTM revenue stands at $1.02M.

Frequently asked questions

What is SINTX Technologies Inc's stock price?

SINTX Technologies Inc (SINT) trades at $2.11.

Is SINTX Technologies Inc overvalued?

Smart Value Score 15/100 (Grade F, Strong Sell).

What is the price target of SINTX Technologies Inc (SINT)?

The analyst target price is $10.17, representing +382.0% upside from the current price of $2.11.

What is SINTX Technologies Inc's revenue?

TTM revenue is $1.02M.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-44.77 — distress.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.sintx.com

Quick metrics

P/S ratio8.71x

ROE-303.80%

Beta0.66

50D MA$2.70

200D MA$3.37

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

SINT vs LLY →SINT vs JNJ →SINT vs ABBV →Stock screener →